drug protocol number

ITCA 650-CLP-105

drug sponsor

Intarcia Therapeutics

drug study

ITCA 650

drug trial site

King Abdulaziz Medical City NG (Jeddah)_ King Abdulaziz Hospital NG (Al Ahsa)_ Imam Abdulrahman Al Faisal Hospital NG (Dammam)_ King Fahad Medical City (Riyadh)

drug status

Completed

drug phase